Introducing Axial Chirality into Mesoionic 4,4′-Bis(1,2,3-triazole) Dicarbenes

Mesoionic 4,4′-bis(1,2,3-triazole-5,5′-diylidene) Rh(I) complexes having a C2 chiral 4,4′-axis were accessed from 3-alkyltriazolium salts in virtually complete de. Their structure and configurational integrity were assessed by NMR spectroscopy, X-ray crystallography, and chiral HPLC. Computational analysis of the MICs involved in the reaction suggested the formation of a highly stable and unprecedented cation-carbene intermediate species, which could be evidenced experimentally by cyclic voltammetry analysis

Uncertainty-aware dynamic reliability analysis framework for complex systems

YesCritical technological systems exhibit complex dynamic characteristics such as time-dependent behavior, functional dependencies among events, sequencing and priority of causes that may alter the effects of failure. Dynamic fault trees (DFTs) have been used in the past to model the failure logic of such systems, but the quantitative analysis of DFTs has assumed the existence of precise failure data and statistical independence among events, which are unrealistic assumptions. In this paper, we propose an improved approach to reliability analysis of dynamic systems, allowing for uncertain failure data and statistical and stochastic dependencies among events. In the proposed framework, DFTs are used for dynamic failure modeling. Quantitative evaluation of DFTs is performed by converting them into generalized stochastic Petri nets. When failure data are unavailable, expert judgment and fuzzy set theory are used to obtain reasonable estimates. The approach is demonstrated on a simplified model of a cardiac assist system.DEIS H2020 Project under Grant 732242

EPIdemiology of Surgery-Associated Acute Kidney Injury (EPIS-AKI) : Study protocol for a multicentre, observational trial

More than 300 million surgical procedures are performed each year. Acute kidney injury (AKI) is a common complication after major surgery and is associated with adverse short-term and long-term outcomes. However, there is a large variation in the incidence of reported AKI rates. The establishment of an accurate epidemiology of surgery-associated AKI is important for healthcare policy, quality initiatives, clinical trials, as well as for improving guidelines. The objective of the Epidemiology of Surgery-associated Acute Kidney Injury (EPIS-AKI) trial is to prospectively evaluate the epidemiology of AKI after major surgery using the latest Kidney Disease: Improving Global Outcomes (KDIGO) consensus definition of AKI. EPIS-AKI is an international prospective, observational, multicentre cohort study including 10 000 patients undergoing major surgery who are subsequently admitted to the ICU or a similar high dependency unit. The primary endpoint is the incidence of AKI within 72 hours after surgery according to the KDIGO criteria. Secondary endpoints include use of renal replacement therapy (RRT), mortality during ICU and hospital stay, length of ICU and hospital stay and major adverse kidney events (combined endpoint consisting of persistent renal dysfunction, RRT and mortality) at day 90. Further, we will evaluate preoperative and intraoperative risk factors affecting the incidence of postoperative AKI. In an add-on analysis, we will assess urinary biomarkers for early detection of AKI. EPIS-AKI has been approved by the leading Ethics Committee of the Medical Council North Rhine-Westphalia, of the Westphalian Wilhelms-University Münster and the corresponding Ethics Committee at each participating site. Results will be disseminated widely and published in peer-reviewed journals, presented at conferences and used to design further AKI-related trials. Trial registration number NCT04165369

Probabilistic forecasting informed failure prognostics framework for improved RUL prediction under uncertainty: A transformer case study

The energy transition towards resilient and sustainable power plants requires moving from periodic health assessment to condition-based lifetime planning, which in turn, creates new challenges and opportunities for health estimation and prediction. Probabilistic forecasting models are being widely employed to predict the likely evolution of power grid parameters, such as weather prediction models and probabilistic load forecasting models, that precisely impact on the health state of power and energy components. These models synthesize forecasting knowledge and associated uncertainty information, and their integration within asset management practice would improve lifetime estimation under uncertainty through uncertainty-aware probabilistic predictions. Accordingly, this paper presents a probabilistic prognostics method for lifetime planning under uncertainty integrating data-driven probabilistic forecasting models with expert-knowledge based Bayesian filtering methods. The proposed concepts are applied and validated with power transformers operated in two different power generation systems and obtained results confirm that the proposed probabilistic transformer lifetime estimate aids in the decision-making process with informative lifetime distributions and associated confidence intervals

Transformation of femtoliter metal cups to oxide cups: Chemical mapping by scanning Auger spectroscopy

Cup-like structures of In, Sn and Nb on Si substrates with femtoliter capacity obtained by pulsed laser ablation, have been subjected to different oxidation treatments and examined employing spatially resolved scanning Auger spectroscopy and microscopy (SR-AES and SAM). The as-prepared cups, when exposed to ambient are found to have a native oxide layer on the surface that could be easily removed by Ar ion sputtering to result in clean metal cups, suitable for functionalization. In the case of In cups, the thin metal layer at the bottom of the cups could be removed easily by sputtering to form In rings. The cups subjected to external oxidation have a thicker oxide layer in comparison to in-situ dosing of oxygen. In the case of Nb cups, the high temperature treatment employed during oxidation resulted in segregation of Si to the surface of the cup. There is also evidence for the formation of metal-silicon alloy at the center of the cups, especially of Sn and Nb, during the oxidation treatment at elevated temperatures

EPIdemiology of Surgery-Associated Acute Kidney Injury (EPIS-AKI): Study protocol for a multicentre, observational trial

Introduction More than 300 million surgical procedures are performed each year. Acute kidney injury (AKI) is a common complication after major surgery and is associated with adverse short-term and long-term outcomes. However, there is a large variation in the incidence of reported AKI rates. The establishment of an accurate epidemiology of surgery-associated AKI is important for healthcare policy, quality initiatives, clinical trials, as well as for improving guidelines. The objective of the Epidemiology of Surgery-associated Acute Kidney Injury (EPIS-AKI) trial is to prospectively evaluate the epidemiology of AKI after major surgery using the latest Kidney Disease: Improving Global Outcomes (KDIGO) consensus definition of AKI. Methods and analysis EPIS-AKI is an international prospective, observational, multicentre cohort study including 10 000 patients undergoing major surgery who are subsequently admitted to the ICU or a similar high dependency unit. The primary endpoint is the incidence of AKI within 72 hours after surgery according to the KDIGO criteria. Secondary endpoints include use of renal replacement therapy (RRT), mortality during ICU and hospital stay, length of ICU and hospital stay and major adverse kidney events (combined endpoint consisting of persistent renal dysfunction, RRT and mortality) at day 90. Further, we will evaluate preoperative and intraoperative risk factors affecting the incidence of postoperative AKI. In an add-on analysis, we will assess urinary biomarkers for early detection of AKI. Ethics and dissemination EPIS-AKI has been approved by the leading Ethics Committee of the Medical Council North Rhine-Westphalia, of the Westphalian Wilhelms-University Münster and the corresponding Ethics Committee at each participating site. Results will be disseminated widely and published in peer-reviewed journals, presented at conferences and used to design further AKI-related trials. Trial registration number NCT04165369.